Results 151 to 160 of about 34,660 (225)

[Impact of Integrating Social Information into Clinical Records]. [PDF]

Aten Primaria
Mir Sánchez C.
europepmc   +1 more source

A Prospective Study of Lipid Profile in Incident Patients on Peritoneal Dialysis. [PDF]

Arq Bras Cardiol
Araújo LKRP, Dias DB, Santana MFM, Pereira BJ, Abensur H, Moyses R, Passarelli M, Elias RM.   +7 more
europepmc   +1 more source

Decreased Insulin Levels in Patients with Acute Chagas Disease from Brazilian Amazon treated with Benznidazole. [PDF]

Arq Bras Cardiol
Barbosa-Ferreira JM, Ortiz JV, Pessoa FG, Barbosa MDGV, Guerra JAO, Couceiro KDN, Silva MRHSE, Monteiro MM, Fonseca KCB, Ramires FA, Ianni BM, Mady C, Fernandes F.   +12 more
europepmc   +1 more source

KIM-1 as a biomarker of kidney tubular damage in normoalbuminuric patients with type 2 diabetes mellitus and insulin resistance. [PDF]

J Bras Nefrol
Oliveira LE, Paniz C, Moresco RN, Carvalho JAM.   +3 more
europepmc   +1 more source

[Phenotypic Classification of Diabetes: A Personalized Approach for Pharmaceutical Practice].

Farm Comunitarios
García Soláns J.
europepmc   +1 more source

[Comment on the article: "Main clinical factors associated with hypoglycemia in patients with type 2 diabetes"]. [PDF]

Rev Med Inst Mex Seguro Soc
Mendoza-Abarca JE.
europepmc   +1 more source

Construction and assessment of the quality of a care protocol for insulin use in hospitalized children and adolescents. [PDF]

Rev Bras Enferm
Lavor SA, Sordi CC, Freire VAL, Correia DL, Carvalho REFL, Magalhães FJ, Oliveira SKP.   +6 more
europepmc   +1 more source

[Answer to "Comment on the article: "Diagnostic performance of the FINDRISC questionnaire to identify insulin resistance in adults""]. [PDF]

Rev Med Inst Mex Seguro Soc
Varela-Vega Y, Roy-García IA, Pérez-Rodríguez M, Velázquez-López L.   +3 more
europepmc   +1 more source

[Hypoglycemia in a patient with pleural solitary fibrous tumor and response to pasireotide] [PDF]

Rev Fac Cien Med Univ Nac Cordoba
Videla EK, Ferrada P, Miller J, Torres E, Álvarez A, Herrera J, De la Torre B.   +6 more
europepmc   +1 more source

[Side effects and pharmacovigilance of GLP1 agonists]. [PDF]

Aten Primaria
Maria Tablado MA.
europepmc   +1 more source